
| New York | 001-00035 | 14-0689340 | |||||||||||||||||||||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|||||||||||||||||||||
| 1 Neumann Way, | Evendale, | OH | 45215 | ||||||||||||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||||||||||||||
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||||
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|||||||
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||||
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||||
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
||||||
Common stock, par value $0.01 per share |
GE |
New York Stock Exchange |
||||||
1.875% Notes due 2027 |
GE 27E |
New York Stock Exchange |
||||||
1.500% Notes due 2029 |
GE 29 |
New York Stock Exchange |
||||||
7 1/2% Guaranteed Subordinated Notes due 2035 |
GE /35 |
New York Stock Exchange |
||||||
2.125% Notes due 2037 |
GE 37 |
New York Stock Exchange |
||||||
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). | ||||||||
| Emerging growth company | ☐ | |||||||
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. | ☐ | |||||||
| General Electric Company | |||||||||||
(Registrant) |
|||||||||||
| |
|||||||||||
Date: January 22, 2026 |
/s/ Robert Giglietti | ||||||||||
|
Robert Giglietti
Vice President - Chief Accounting Officer, Controller and Treasurer
Principal Accounting Officer
|
|||||||||||

| Three Months Ended December 31 | Twelve months ended December 31 | ||||||||||||||||||||||
Dollars in millions; per-share amounts in dollars, diluted |
2025 | 2024 | Year on Year | 2025 | 2024 | Year on Year | |||||||||||||||||
| GAAP Metrics | |||||||||||||||||||||||
Total Revenue |
$12,717 | $10,812 | 18 | % | $45,855 | $38,702 | 18 | % | |||||||||||||||
| Profit | 2,851 | 2,293 | 24 | % | 10,000 | 7,620 | 31 | % | |||||||||||||||
| Profit Margin | 22.4 | % | 21.2 | % | 120 bps | 21.8 | % | 19.7 | % | 210 bps | |||||||||||||
| Continuing EPS | 2.31 | 1.75 | 32 | % | 8.05 | 6.09 | 32 | % | |||||||||||||||
| Cash from Operating Activities (CFOA) | 2,096 | 1,318 | 59 | % | 8,543 | 5,817 | 47 | % | |||||||||||||||
| Non-GAAP Metrics | |||||||||||||||||||||||
| Adjusted Revenue | $11,865 | $9,879 | 20 | % | $42,322 | $35,121 | 21 | % | |||||||||||||||
Operating Profit |
2,273 | 1,988 | 14 | % | 9,055 | 7,253 | 25 | % | |||||||||||||||
Operating Profit Margin |
19.2 | % | 20.1 | % | (90) bps | 21.4 | % | 20.7 | % | 70 bps | |||||||||||||
| Adjusted EPS | 1.57 | 1.32 | 19 | % | 6.37 | 4.60 | 38 | % | |||||||||||||||
| Free Cash Flow (FCF) | 1,760 | 1,529 | 15 | % | 7,694 | 6,203 | 24 | % | |||||||||||||||
|
|
2025 | 2026 Guide |
||||||
|
Adjusted Revenue* Growth
Adjusted Revenue*
|
'+21%
$42.3B
|
'+ LDD |
||||||
|
Operating Profit*
Operating profit margin*
|
$9.1B
21.4%
|
$9.85B - $10.25B |
||||||
| Adjusted EPS* | $6.37 | $7.10 - $7.40 |
||||||
|
Free Cash Flow*
FCF* conversion-a)
|
$7.7B
113%
|
$8.0B - $8.4B
>100%
|
||||||
|
|
2025 Revised-b) |
2026 Guide |
||||||
| CES Services Revenue | $24.2B |
'+ Mid-teens |
||||||
| CES Equipment Revenue | $7.7B |
'+ Mid/High-teens |
||||||
Commercial Engines & Services (CES) Revenue |
$31.9B |
'+ Mid-teens |
||||||
Defense & Propulsion Technologies (DPT) Revenue |
$12.2B |
'+ MSD/HSD |
||||||
Commercial Engines & Services (CES) Operating Profit |
$8.6B |
$9.6 - $9.9B |
||||||
Defense & Propulsion Technologies (DPT) Operating Profit |
$1.5B |
$1.55 - $1.65B |
||||||
Corporate Cost & Eliminations Operating Profit*-c) |
$(1.0)B |
$(1.2) - $(1.3)B |
||||||
| Three months ended December 31 | Twelve months ended December 31 | ||||||||||||||||||||||||||||
(Dollars in millions) |
2025 | 2024 | Year on Year | 2025 | 2024 | Year on Year | |||||||||||||||||||||||
| Orders | $22,842 | $12,947 | 76 | % | $54,415 | $40,213 | 35 | % | |||||||||||||||||||||
| Revenue | 9,468 | 7,650 | 24 | % | 33,314 | 26,881 | 24 | % | |||||||||||||||||||||
| Operating profit/(loss) | 2,273 | 2,158 | 5 | % | 8,861 | 7,055 | 26 | % | |||||||||||||||||||||
| Operating profit/(loss) margin | 24.0 | % | 28.2 | % | (420) | bps |
26.6 | % | 26.2 | % | 40 | bps |
|||||||||||||||||
| Three months ended December 31 | Twelve months ended December 31 | ||||||||||||||||||||||||||||
(Dollars in millions) |
2025 | 2024 | Year on Year | 2025 | 2024 | Year on Year | |||||||||||||||||||||||
| Orders | $4,571 | $2,840 | 61 | % | $13,397 | $11,248 | 19 | % | |||||||||||||||||||||
| Revenue | 2,839 | 2,523 | 13 | % | 10,554 | 9,478 | 11 | % | |||||||||||||||||||||
| Operating profit/(loss) | 252 | 241 | 5 | % | 1,296 | 1,061 | 22 | % | |||||||||||||||||||||
| Operating profit/(loss) margin | 8.9 | % | 9.6 | % | (70) | bps |
12.3 | % | 11.2 | % | 110 | bps |
|||||||||||||||||
| STATEMENT OF OPERATIONS (UNAUDITED) | Three months ended December 31 | Twelve months ended December 31 | |||||||||||||||
| (In millions; per-share amounts in dollars) | 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Sales of equipment | $ | 3,500 | $ | 3,230 | $ | 12,159 | $ | 10,274 | |||||||||
| Sales of services | 8,365 | 6,649 | 30,163 | 24,847 | |||||||||||||
| Insurance revenue | 852 | 933 | 3,533 | 3,581 | |||||||||||||
| Total revenue | 12,717 | 10,812 | 45,855 | 38,702 | |||||||||||||
| Cost of equipment sold | 3,931 | 2,950 | 12,382 | 10,341 | |||||||||||||
| Cost of services sold | 4,432 | 3,811 | 16,586 | 13,967 | |||||||||||||
| Selling, general and administrative expenses | 997 | 1,157 | 4,088 | 4,437 | |||||||||||||
| Separation costs | 52 | 84 | 202 | 492 | |||||||||||||
| Research and development | 448 | 385 | 1,580 | 1,286 | |||||||||||||
| Interest and other financial charges | 250 | 224 | 843 | 986 | |||||||||||||
| Insurance losses, annuity benefits and other costs | 550 | 421 | 2,449 | 2,429 | |||||||||||||
| Goodwill impairments | — | — | — | 251 | |||||||||||||
| Non-operating benefit cost (income) | (192) | (213) | (788) | (842) | |||||||||||||
| Total costs and expenses | 10,468 | 8,818 | 37,342 | 33,346 | |||||||||||||
| Other income (loss) | 602 | 299 | 1,487 | 2,264 | |||||||||||||
| Net income (loss) from continuing operations before income taxes | 2,851 | 2,293 | 10,000 | 7,620 | |||||||||||||
| Benefit (provision) for income taxes | (390) | (396) | (1,405) | (962) | |||||||||||||
| Net income (loss) from continuing operations | 2,461 | 1,897 | 8,595 | 6,657 | |||||||||||||
| Earnings (loss) from discontinued operations, net of taxes | 89 | (6) | 103 | (91) | |||||||||||||
| Net income (loss) | 2,550 | 1,891 | 8,698 | 6,566 | |||||||||||||
| Less net income (loss) attributable to noncontrolling interests | 10 | (8) | (6) | 11 | |||||||||||||
| Net income (loss) attributable to the Company | 2,541 | 1,899 | 8,704 | 6,556 | |||||||||||||
| Net income (loss) attributable to common shareholders | $ | 2,541 | $ | 1,899 | $ | 8,704 | $ | 6,556 | |||||||||
| Earnings (loss) per share from continuing operations | |||||||||||||||||
| Diluted earnings (loss) per share | $ | 2.31 | $ | 1.75 | $ | 8.05 | $ | 6.09 | |||||||||
| Basic earnings (loss) per share | $ | 2.33 | $ | 1.77 | $ | 8.11 | $ | 6.15 | |||||||||
| Net earnings (loss) per share | |||||||||||||||||
| Diluted earnings (loss) per share | $ | 2.40 | $ | 1.75 | $ | 8.14 | $ | 5.99 | |||||||||
| Basic earnings (loss) per share | $ | 2.42 | $ | 1.76 | $ | 8.20 | $ | 6.04 | |||||||||
| STATEMENT OF FINANCIAL POSITION (UNAUDITED) | ||||||||
(In millions) |
December 31, 2025 | December 31, 2024 | ||||||
| Cash, cash equivalents and restricted cash | $ | 12,392 | $ | 13,619 | ||||
| Investment securities | — | 982 | ||||||
| Current receivables | 11,773 | 9,327 | ||||||
| Inventories, including deferred inventory costs | 11,868 | 9,763 | ||||||
| Current contract assets | 3,511 | 2,982 | ||||||
| All other current assets | 1,052 | 962 | ||||||
| Current assets | 40,596 | 37,635 | ||||||
| Investment securities | 38,788 | 37,741 | ||||||
| Property, plant and equipment – net | 7,987 | 7,277 | ||||||
| Goodwill | 9,060 | 8,538 | ||||||
| Other intangible assets – net | 4,225 | 4,257 | ||||||
| Contract and other deferred assets | 4,920 | 4,831 | ||||||
| All other assets | 15,277 | 13,910 | ||||||
| Deferred income taxes | 7,459 | 7,111 | ||||||
| Assets of discontinued operations | 1,855 | 1,841 | ||||||
Total assets |
$ | 130,169 | $ | 123,140 | ||||
| Short-term borrowings | $ | 1,686 | $ | 2,039 | ||||
| Accounts payable | 10,078 | 7,909 | ||||||
| Progress collections | 7,662 | 6,695 | ||||||
| Contract liabilities and deferred income | 10,333 | 9,353 | ||||||
| Sales discounts and allowances | 4,037 | 3,475 | ||||||
| All other current liabilities | 5,185 | 4,920 | ||||||
| Current liabilities | 38,980 | 34,392 | ||||||
| Deferred income | 1,065 | 1,013 | ||||||
| Long-term borrowings | 18,808 | 17,234 | ||||||
| Insurance liabilities and annuity benefits | 36,894 | 36,209 | ||||||
| Non-current compensation and benefits | 6,833 | 7,035 | ||||||
| All other liabilities | 7,276 | 6,376 | ||||||
| Liabilities of discontinued operations | 1,413 | 1,317 | ||||||
Total liabilities |
111,271 | 103,576 | ||||||
|
Common stock (1,048,766,702 and 1,073,692,183 shares outstanding
at December 31, 2025 and December 31, 2024, respectively)
|
15 | 15 | ||||||
| Accumulated other comprehensive income (loss) – net attributable to the Company | (4,798) | (3,861) | ||||||
Other capital |
23,599 | 24,266 | ||||||
Retained earnings |
87,663 | 80,488 | ||||||
Less common stock held in treasury |
(87,801) | (81,566) | ||||||
| Total shareholders’ equity | 18,677 | 19,342 | ||||||
| Noncontrolling interests | 221 | 223 | ||||||
| Total equity | 18,898 | 19,564 | ||||||
Total liabilities and equity |
$ | 130,169 | $ | 123,140 | ||||
| ADJUSTED REVENUE, OPERATING PROFIT AND PROFIT MARGIN (NON-GAAP) | Three months ended December 31 | Twelve months ended December 31 | |||||||||||||||||||||
| (Dollars in millions) | 2025 | 2024 | V% | 2025 | 2024 | V% | |||||||||||||||||
| Total revenue (GAAP) | $ | 12,717 | $ | 10,812 | 18 | % | $ | 45,855 | $ | 38,702 | 18 | % | |||||||||||
| Less: Insurance revenue | 852 | 933 | 3,533 | 3,581 | |||||||||||||||||||
| Adjusted revenue (Non-GAAP) | $ | 11,865 | $ | 9,879 | 20 | % | $ | 42,322 | $ | 35,121 | 21 | % | |||||||||||
| Total costs and expenses (GAAP) | $ | 10,468 | $ | 8,818 | 19 | % | $ | 37,342 | $ | 33,346 | 12 | % | |||||||||||
| Less: Insurance cost and expenses | 574 | 452 | 2,541 | 2,560 | |||||||||||||||||||
Less: U.S. tax equity cost and expenses |
5 | 5 | 20 | 14 | |||||||||||||||||||
| Less: interest and other financial charges | 250 | 224 | 843 | 986 | |||||||||||||||||||
| Less: non-operating benefit cost (income) | (192) | (213) | (788) | (842) | |||||||||||||||||||
| Less: restructuring & other | (136) | — | (87) | 525 | |||||||||||||||||||
| Less: goodwill impairments | — | — | — | 251 | |||||||||||||||||||
| Less: separation costs | 52 | 83 | 202 | 492 | |||||||||||||||||||
| Add: noncontrolling interests | 10 | (8) | (6) | (13) | |||||||||||||||||||
| Adjusted costs (Non-GAAP) | $ | 9,925 | $ | 8,259 | 20 | % | $ | 34,606 | $ | 29,348 | 18 | % | |||||||||||
| Other income (loss) (GAAP) | $ | 602 | $ | 299 | F | $ | 1,487 | $ | 2,264 | (34) | % | ||||||||||||
Less: U.S. tax equity |
(27) | (25) | (169) | (146) | |||||||||||||||||||
| Less: gains (losses) on retained and sold ownership interests and other equity securities | 294 | (66) | 312 | 532 | |||||||||||||||||||
Less: gains (losses) on purchases and sales of business interests |
2 | 23 | 5 | 398 | |||||||||||||||||||
| Adjusted other income (loss) (Non-GAAP) | $ | 333 | $ | 368 | (10) | % | $ | 1,339 | $ | 1,480 | (10) | % | |||||||||||
| Profit (loss) (GAAP) | $ | 2,851 | $ | 2,293 | 24 | % | $ | 10,000 | $ | 7,620 | 31 | % | |||||||||||
| Profit (loss) margin (GAAP) | 22.4 | % | 21.2 | % | 120 bps | 21.8 | % | 19.7 | % | 210 bps | |||||||||||||
Operating profit (loss) (Non-GAAP) |
$ | 2,273 | $ | 1,988 | 14 | % | $ | 9,055 | $ | 7,253 | 25% | ||||||||||||
Operating profit (loss) margin (Non-GAAP) |
19.2 | % | 20.1 | % | (90) bps | 21.4 | % | 20.7 | % | 70 bps | |||||||||||||
| We believe that adjusting revenue provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of revenue from our run-off insurance operations. We believe that adjusting profit to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability. Gains (losses) and restructuring and other items are impacted by the timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities. We also use Adjusted revenue* and Operating profit* as performance metrics at the company level for our annual executive incentive plan for 2025. | |||||||||||||||||||||||
| ADJUSTED NET INCOME (LOSS) (NON-GAAP) | Three months ended December 31 | Twelve months ended December 31 | |||||||||||||||||||||||||||||||||
| (In millions, diluted, per-share amounts in dollars) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||||
| Income | EPS | Income | EPS | Income | EPS | Income | EPS | ||||||||||||||||||||||||||||
| Net income (loss) from continuing operations (GAAP) | $ | 2,452 | $ | 2.31 | $ | 1,905 | $ | 1.75 | $ | 8,598 | $ | 8.05 | $ | 6,670 | $ | 6.09 | |||||||||||||||||||
| Insurance net income (loss) (pre-tax) | 282 | 0.27 | 482 | 0.44 | 1,002 | 0.94 | 1,025 | 0.94 | |||||||||||||||||||||||||||
Tax effect on Insurance net income (loss)(a) |
(40) | (0.04) | (103) | (0.09) | (125) | (0.12) | (219) | (0.20) | |||||||||||||||||||||||||||
| Less: Insurance net income (loss) (net of tax) | 242 | 0.23 | 379 | 0.35 | 877 | 0.82 | 806 | 0.74 | |||||||||||||||||||||||||||
| U.S. tax equity net income (loss) (pre-tax) | (40) | (0.04) | (37) | (0.03) | (220) | (0.21) | (191) | (0.17) | |||||||||||||||||||||||||||
| Tax effect on U.S. tax equity net income (loss) | 47 | 0.04 | 46 | 0.04 | 259 | 0.24 | 235 | 0.21 | |||||||||||||||||||||||||||
| Less: U.S. tax equity net income (loss) (net of tax) | 7 | 0.01 | 9 | 0.01 | 38 | 0.04 | 44 | 0.04 | |||||||||||||||||||||||||||
| Non-operating benefit (cost) income (pre-tax) (GAAP) | 192 | 0.18 | 213 | 0.20 | 788 | 0.74 | 842 | 0.77 | |||||||||||||||||||||||||||
| Tax effect on non-operating benefit (cost) income | (40) | (0.04) | (45) | (0.04) | (166) | (0.15) | (177) | (0.16) | |||||||||||||||||||||||||||
| Less: Non-operating benefit (cost) income (net of tax) | 152 | 0.14 | 168 | 0.16 | 623 | 0.58 | 665 | 0.61 | |||||||||||||||||||||||||||
Gains (losses) on purchases and sales of business interests (pre-tax) |
2 | — | 23 | 0.02 | 5 | — | 398 | 0.36 | |||||||||||||||||||||||||||
| Tax effect on gains (losses) on purchases and sales of business interests | — | — | 3 | — | 2 | — | (2) | — | |||||||||||||||||||||||||||
| Less: Gains (losses) on purchases and sales of business interests (net of tax) | 2 | — | 25 | 0.02 | 7 | 0.01 | 396 | 0.36 | |||||||||||||||||||||||||||
Gains (losses) on retained and sold ownership interests and other equity securities (pre-tax) |
294 | 0.28 | (66) | (0.06) | 312 | 0.29 | 532 | 0.49 | |||||||||||||||||||||||||||
Tax effect on gains (losses) on retained and sold ownership interests and other equity securities(a)(b) |
(62) | (0.06) | (2) | — | (61) | (0.06) | (3) | — | |||||||||||||||||||||||||||
| Less: Gains (losses) on retained and sold ownership interests and other equity securities (net of tax) | 232 | 0.22 | (68) | (0.06) | 251 | 0.23 | 529 | 0.48 | |||||||||||||||||||||||||||
Restructuring & other (pre-tax) |
136 | 0.13 | — | — | 87 | 0.08 | (525) | (0.48) | |||||||||||||||||||||||||||
| Tax effect on restructuring & other | (29) | (0.03) | — | — | (18) | (0.02) | 110 | 0.10 | |||||||||||||||||||||||||||
| Less: Restructuring & other (net of tax) | 107 | 0.10 | — | — | 69 | 0.06 | (415) | (0.38) | |||||||||||||||||||||||||||
| Goodwill impairments (pre-tax) | — | — | — | — | — | — | (251) | (0.23) | |||||||||||||||||||||||||||
| Tax effect on goodwill impairments | — | — | 3 | — | — | — | 3 | — | |||||||||||||||||||||||||||
| Less: goodwill impairments (net of tax) | — | — | 3 | — | — | — | (248) | (0.23) | |||||||||||||||||||||||||||
Separation costs (pre-tax) |
(57) | (0.05) | (83) | (0.08) | (207) | (0.19) | (492) | (0.45) | |||||||||||||||||||||||||||
| Tax effect on separation costs | 98 | 0.09 | 37 | 0.03 | 129 | 0.12 | 349 | 0.32 | |||||||||||||||||||||||||||
| Less: Separation costs (net of tax) | 41 | 0.04 | (46) | (0.04) | (79) | (0.07) | (143) | (0.13) | |||||||||||||||||||||||||||
| Adjusted net income (loss) (Non-GAAP) | $ | 1,667 | $ | 1.57 | $ | 1,433 | $ | 1.32 | $ | 6,812 | $ | 6.37 | $ | 5,035 | $ | 4.60 | |||||||||||||||||||
(a) Includes related tax valuation allowances. Tax effect on Insurance net income includes valuation allowances for 2025. | |||||||||||||||||||||||||||||||||||
(b) Includes tax benefits available to offset the tax on gains (losses) on equity securities. | |||||||||||||||||||||||||||||||||||
| Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total. | |||||||||||||||||||||||||||||||||||
| We believe that Adjusted net income* provides management and investors with useful measures to evaluate the performance of the total company and increased period-to-period comparability, as well as a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding items that are not closely related with ongoing operations. We also use Adjusted EPS* as a performance metric at the company level for our performance stock units granted in 2025. | |||||||||||||||||||||||||||||||||||
| FREE CASH FLOW (FCF) (NON-GAAP) | Three months ended December 31 | Twelve months ended December 31 | |||||||||||||||||||||
| (In millions) | 2025 | 2024 | V% | 2025 | 2024 | V% | |||||||||||||||||
| Cash flows from operating activities (CFOA) (GAAP) | $ | 2,096 | $ | 1,318 | 59 | % | $ | 8,543 | $ | 5,817 | 47 | % | |||||||||||
| Add: gross additions to property, plant and equipment and internal-use software | (431) | (267) | (1,273) | (1,032) | |||||||||||||||||||
| Add: dispositions of property, plant and equipment | 47 | 12 | 123 | 114 | |||||||||||||||||||
Less: separation cash expenditures |
(43) | (85) | (245) | (800) | |||||||||||||||||||
| Less: Corporate & Other restructuring cash expenditures | (5) | (381) | (56) | (504) | |||||||||||||||||||
| Free cash flow (FCF) (Non-GAAP) | $ | 1,760 | $ | 1,529 | 15 | % | $ | 7,694 | $ | 6,203 | 24 | % | |||||||||||
| Free cash flow (Non-GAAP) conversion % | 106 | % | 107 | % | 113 | % | 123 | % | |||||||||||||||
| We believe investors may find it useful to compare free cash flow* performance without the effects of separation cash expenditures and Corporate & Other restructuring cash expenditures (associated with the separation-related program announced in the fourth quarter of 2022). In addition, beginning in the third quarter of 2025, we now include dispositions of property, plant and equipment. We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flow*. We also use FCF* as a performance metric at the company level for our annual executive incentive plan and performance stock units granted in 2025. | |||||||||||||||||||||||
REVENUE AND OPERATING PROFIT (COST) (in billions) |
2025 Revised |
||||
Insurance revenue |
$ | 3.5 | |||
| Eliminations and other | (1.8) | ||||
| Corporate & Other revenue | $ | 1.7 | |||
| Gains (losses) on purchases and sales of business interests | — | ||||
Gains (losses) on retained and sold ownership interests and other equity securities |
0.3 | ||||
Restructuring and other charges |
0.1 | ||||
Separation costs |
(0.2) | ||||
Insurance profit (loss) |
1.0 | ||||
| U.S. tax equity profit (loss) | (0.2) | ||||
Goodwill impairments |
— | ||||
| Adjusted Corporate & Other operating costs (Non-GAAP) | (1.0) | ||||
| Corporate & Other operating profit (cost) (GAAP) | $ | — | |||
| Less: gains (losses), impairments, Insurance, and restructuring & other | 1.0 | ||||
| Adjusted Corporate & Other operating costs (Non-GAAP) | $ | (1.0) | |||
| Corporate & Other profit (costs) | (0.5) | ||||
| Eliminations | (0.6) | ||||
| Adjusted Corporate & Other operating costs (Non-GAAP) | $ | (1.0) | |||
Adjusted Corporate & Other operating costs* excludes gains (losses) on purchases and sales of business interests, gains (losses) on retained and sold ownership interests and other equity securities, higher-cost restructuring programs, separation costs, our run-off insurance operations, U.S. tax equity profit (loss) and goodwill impairments. We believe that adjusting Corporate & Other costs to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability of our ongoing corporate costs. | |||||
2026 GUIDANCE: 2026 OPERATING PROFIT (NON-GAAP) | ||||||||||||||||||||
We cannot provide a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measure for Operating profit* in 2026 without unreasonable effort due to the uncertainty of timing of any gains or losses related to acquisitions & dispositions, the timing and magnitude of the financial impact related to the mark-to-market of our investment in BETA Technologies, Inc. and the timing and magnitude of restructuring expenses. Although we have attempted to estimate the amount of gains and restructuring charges for the purpose of explaining the probable significance of these components, this calculation involves a number of unknown variables, resulting in a GAAP range that we believe is too large and variable to be meaningful. | ||||||||||||||||||||
2026 GUIDANCE: 2026 ADJUSTED EPS (NON-GAAP) | ||||||||||||||||||||
We cannot provide a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measure for Adjusted EPS* in 2026 without unreasonable effort due to the uncertainty of timing of any gains or losses related to acquisitions & dispositions, the timing and magnitude of the financial impact related to the mark-to-market of our investment in BETA Technologies, Inc. and the timing and magnitude of restructuring expenses. Although we have attempted to estimate the amount of gains and restructuring charges for the purpose of explaining the probable significance of these components, this calculation involves a number of unknown variables, resulting in a GAAP range that we believe is too large and variable to be meaningful. | ||||||||||||||||||||
2026 GUIDANCE: 2026 ADJUSTED CORPORATE AND OTHER OPERATING COSTS (NON-GAAP) | ||||||||||||||||||||
We cannot provide a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measure for Adjusted Corporate and other operating costs* in 2026 without unreasonable effort due to the uncertainty of timing of any gains or losses related to acquisitions & dispositions, the timing and magnitude of the financial impact related to the mark-to-market of our investment in BETA Technologies, Inc. and the timing and magnitude of restructuring expenses. Although we have attempted to estimate the amount of gains and restructuring charges for the purpose of explaining the probable significance of these components, this calculation involves a number of unknown variables, resulting in a GAAP range that we believe is too large and variable to be meaningful. | ||||||||||||||||||||
2026 GUIDANCE: 2026 FCF (NON-GAAP) | |||||||||||||||||
We cannot provide a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measure for free cash flow* in 2026 without unreasonable effort due to the uncertainty of timing for capital expenditures and restructuring related cash expenditures. | |||||||||||||||||